A
Alberto Albanese
Researcher at The Catholic University of America
Publications - 403
Citations - 29293
Alberto Albanese is an academic researcher from The Catholic University of America. The author has contributed to research in topics: Dystonia & Parkinson's disease. The author has an hindex of 75, co-authored 384 publications receiving 26667 citations. Previous affiliations of Alberto Albanese include University Hospital of Lausanne & Harefield Hospital.
Papers
More filters
Journal ArticleDOI
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Eriza Maria Valente,Patrick M. Abou-Sleiman,Viviana Caputo,Miratul M. K. Muqit,Kirsten Harvey,Suzana Gispert,Zeeshan Ali,Domenico Del Turco,Anna Rita Bentivoglio,Daniel G. Healy,Alberto Albanese,Robert L. Nussbaum,Rafael González-Maldonado,Thomas Deller,S Salvi,Pietro Cortelli,William P. Gilks,David S. Latchman,Roberk J. Harvey,Bruno Dallapiccola,Georg Auburger,Nicholas W. Wood +21 more
TL;DR: The identification of two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families provide a direct molecular link between mitochondria and the pathogenesis of PD.
Journal ArticleDOI
Phenomenology and classification of dystonia: a consensus update.
Alberto Albanese,Kailash P. Bhatia,Susan B. Bressman,Mahlon R. DeLong,Stanley Fahn,Victor S.C. Fung,Mark Hallett,Joseph Jankovic,Hyder A. Jinnah,Christine Klein,Anthony E. Lang,Jonathan W. Mink,Jan K. Teller +12 more
TL;DR: An international panel consisting of investigators with years of experience in this field that reviewed the definition and classification of dystonia provides a new general definition and proposes a new classification and encourages clinicians and researchers to use these innovative definitions and test them in the clinical setting on a variety of patients with Dystonia.
Journal Article
Consensus statement on the diagnosis of multiple system atrophy.
Sid Gilman,Phillip A. Low,Niall Quinn,Alberto Albanese,Yoav Ben-Shlomo,C. J. Fowler,Horacio Kaufmann,Thomas Klockgether,Anthony E. Lang,P. L. Lantos,Irene Litvan,Christopher J. Mathias,E. Oliver,D. Robertson,Irwin J. Schatz,Gregor K. Wenning +15 more
TL;DR: The clinical features of the disease, which include four domains: autonomic failure/urinary dysfunction, parkinsonism and cerebellar ataxia, and corticospinal dysfunction, are described and criteria to define the relative importance of these features are set.
Journal ArticleDOI
Rivastigmine for Dementia Associated with Parkinson's Disease
Murat Emre,Dag Aarsland,Alberto Albanese,E. J. Byrne,Günther Deuschl,P.P. De Deyn,Franck Durif,Jaime Kulisevsky,T. van Laar,Alan Lees,Werner Poewe,A Robillard,MM Rosa,Erik Ch. Wolters,P Quarg,Sibel Tekin,Roger Lane +16 more
TL;DR: In this paper, the effects of the dual cholinesterase inhibitor rivastigmine in patients with mild-to-moderate dementia associated with Parkinson's disease were investigated.
Journal ArticleDOI
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
M.C. Rodríguez-Oroz,Jose A. Obeso,Anthony E. Lang,J. L. Houeto,Pierre Pollak,Stig Rehncrona,Jaume Kulisevsky,Alberto Albanese,Jens Volkmann,Marwan Hariz,Niall Quinn,Johannes D. Speelman,Jorge Guridi,I Zamarbide,Alexandre Gironell,Joan Molet,Berta Pascual-Sedano,Bernard Pidoux,A M Bonnet,Yves Agid,Jing Xie,Alim-Louis Benabid,Andres M. Lozano,Jean A. Saint-Cyr,Luigi Romito,Maria Fiorella Contarino,Massimo Scerrati,Valérie Fraix,N. Van Blercom +28 more
TL;DR: This first multicentre study assessing the long-term efficacy of either STN or GPi stimulation shows a significant and substantial clinically important therapeutic benefit for at least 3-4 years in a large cohort of patients with severe Parkinson's disease.